Patents Assigned to HEMARINA
  • Patent number: 11224218
    Abstract: The present invention relates to isolated haemoglobin from worms belonging to the Nereididae family and its use in cell culture medium, in preservation solutions and as artificial oxygen carrier for transfusion.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: January 18, 2022
    Assignee: HEMARINA
    Inventors: Morgane Rousselot, Delphine Dutheil, Franck Zal
  • Patent number: 11103615
    Abstract: The invention relates to the use of a haemoglobin for the preparation of dressings and to the resulting dressings.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: August 31, 2021
    Assignees: Centre National De La Recherche Scientifique CNRS, Hemarina, Universite Pierre Et Marie Curie
    Inventors: Franck Zal, Morgane Rousselot
  • Patent number: 10988730
    Abstract: The invention relates to a lyophilisate or to a powder including i) at least one globin, a globin protomer or an extracellular hemoglobin from annelids, and ii) at least one biological material from annelids that is different from said globin, from said protomer and from said hemoglobin.
    Type: Grant
    Filed: May 14, 2014
    Date of Patent: April 27, 2021
    Assignee: Hemarina
    Inventor: Franck Zal
  • Patent number: 10119110
    Abstract: The present invention relates to devices and bioreactors capable of delivering oxygen to a cell culture using oxygen-carrying molecules. The bioreactor comprises at least two chambers separated by an oxygen-permeable membrane. The oxygen-carrying molecules are chosen from extracellular hemoglobin isolated from worm belonging to Arenicoliolae family or Nereidiolae family.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: November 6, 2018
    Assignee: HEMARINA
    Inventor: Frank Zal
  • Patent number: 9861095
    Abstract: Disclosed is a method for preserving an organ in a donation after brain death donor or a donation after cardiac death donor comprising administering to the donor a composition comprising at least one globin, one globin protomer or one extracellular hemoglobin of Annelida, a stabilizing solution and/or a solution for conserving organs, said composition having a temperature of between 0° C. and 37° C. Also disclosed is a method for conserving an organ in situ in a donation after brain death donor or a donation after cardiac death donor using normothermic ECMO or double-balloon triple-lumen catheter techniques or any other similar technique.
    Type: Grant
    Filed: May 30, 2012
    Date of Patent: January 9, 2018
    Assignee: HEMARINA
    Inventors: Delphine Dutheil, Morgane Rousselot, Thierry Hauet, Franck Zal
  • Patent number: 9663761
    Abstract: A method for maintaining stem cells in the undifferentiated state by mixing the stem cells with at least one extracellular hemoglobin, globin or globin protomer from annelids.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: May 30, 2017
    Assignee: HEMARINA
    Inventor: Franck Zal
  • Publication number: 20160152944
    Abstract: The invention relates to a lyophilisate or to a powder including i) at least one globin, a globin protomer or an extracellular hemoglobin from annelids, and ii) at least one biological material from annelids that is different from said globin, from said protomer and from said hemoglobin.
    Type: Application
    Filed: May 14, 2014
    Publication date: June 2, 2016
    Applicant: HEMARINA
    Inventor: Franck ZAL
  • Patent number: 9220929
    Abstract: The invention relates to the use of a haemoglobin for the preparation of dressings and to the resulting dressings.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: December 29, 2015
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS, Hemarina, UNIVERSITE PIERRE ET MARIE CURE
    Inventors: Franck Zal, Morgane Rousselot
  • Patent number: 8846306
    Abstract: The invention relates to the use of at least one globin and/or at least one globin protomer and/or at least one naturally extracellular native hemoglobin for the preservation of organs, tissues, organ and tissue cells and cell cultures.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: September 30, 2014
    Assignees: Hemarina SA, Centre National de la Recherche Scientifique, Universite Pierre et Marie Curie (Paris 6)
    Inventors: Franck Zal, Morgane Rousselot, Delphine Dutheil
  • Publication number: 20140220683
    Abstract: A method for maintaining stem cells in the undifferentiated state by mixing the stem cells with at least one extracellular hemoglobin, globin or globin protomer from annelids.
    Type: Application
    Filed: August 23, 2012
    Publication date: August 7, 2014
    Applicant: HEMARINA
    Inventor: Franck Zal
  • Publication number: 20140113274
    Abstract: The invention relates to the use of a composition comprising at least one globin, one globin protomer or one extracellular hemoglobin of Annelida, a stabilizing solution and/or a solution for conserving organs, said composition having a temperature of between 0° C. and 37° C., for preserving an organ in a donation after brain death donor or a donation after cardiac death donor. The invention also relates to a method for conserving an organ in situ in a donation after brain death donor or a donation after cardiac death donor using normothermic ECMO or double-balloon triple-lumen catheter techniques or any other similar technique.
    Type: Application
    Filed: May 30, 2012
    Publication date: April 24, 2014
    Applicant: HEMARINA
    Inventors: Delphine Dutheil, Morgane Rousselot, Thierry Hauet, Franck Zal
  • Publication number: 20120052136
    Abstract: The present invention relates to isolated haemoglobin from worms belonging to the Nereididae family and its use in cell culture medium, in preservation solutions and as artificial oxygen carrier for transfusion.
    Type: Application
    Filed: May 7, 2010
    Publication date: March 1, 2012
    Applicant: HEMARINA
    Inventors: Morgane Rousselot, Delphine Dutheil, Franck Zal
  • Publication number: 20120040453
    Abstract: The present invention relates to devices and bioreactors capable of delivering oxygen to a cell culture using oxygen-carrying molecules. The bioreactor comprises at least two chambers separated by an oxygen-permeable membrane. The oxygen-carrying molecules are chosen from extracellular hemoglobin isolated from worm belonging to Arenicoliolae family or Nereidiolae family.
    Type: Application
    Filed: April 21, 2010
    Publication date: February 16, 2012
    Applicant: HEMARINA
    Inventor: Frank Zal
  • Publication number: 20100278887
    Abstract: The invention relates to the use of a haemoglobin for the preparation of dressings and to the resulting dressings.
    Type: Application
    Filed: June 10, 2008
    Publication date: November 4, 2010
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS, HEMARINA SA, UNIVERSITE PIERRE ET MARIE CURIE
    Inventors: Franck Zal, Morgane Rousselot
  • Publication number: 20100209902
    Abstract: The invention relates to the use of at least one globin and/or at least one globin protomer and/or at least one naturally extracellular native hemoglobin for the preservation of organs, tissues, organ and tissue cells and cell cultures.
    Type: Application
    Filed: July 25, 2008
    Publication date: August 19, 2010
    Applicants: HEMARINA SA, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Franck Zal, Morgane Rousselot, Delphine Dutheil